BD and Burjeel Medical City announce strategic partnership to drive healthcare innovation in the UAE

0
325

Dubai, United Arab
Emirates, June 2nd, 2022
– In a joint effort
to accelerate the UAE’s vision for a world-class healthcare system, the Dubai
Branch of BD (Becton, Dickinson and Company) (NYSE: BDX), and VPS Healthcare’s Burjeel
Medical City (BMC) today announced a strategic partnership that will enable both
organizations to accelerate innovation and deliver healthcare excellence in the
country.

“This partnership is a
cornerstone of our combined efforts to help advance UAE’s healthcare system,”
said Maher Elhassan, Vice President & General Manager, BD Middle East,
North Africa & Turkey. “The continued emphasis on patient safety inspires us
to invest more into innovative collaborations to deliver safety and care to both
patients and healthcare workers, rapid diagnosis, antimicrobial resistance as
well as training of medical practitioners. Together, we will advance the world
of health and positively impact patient lives.”

The
collaboration between BD and Burjeel Medcial City will create valuable
opportunities to offer the healthcare provider with cutting-edge MedTech
innovations in pursuit of offering improved safety and care for patients and
healthcare workers in the UAE. In addition to medtech solutions, this joint
effort will enhance safety practices and measures through providing trainings to
enable a better understanding of advanced solutions and safety procedures.

Speaking about the partnership, John Sunil,
CEO, Burjeel Group  stated “As a leading
healthcare network in UAE, we understand how laboratories play a vital role in
delivering patient care. The Burjeel Medical City’s Central Lab is equipped
with total lab automation, allowing us to connect all our sites across the
U.A.E. with a capacity of nearly 10 million tests per year.

Our collaboration with BD is yet another
important step in our pursuit of constantly delivering healthcare excellence
and improving patient outcomes. This partnership will enable us to detect
emerging antimicrobial resistance, rapidly implement infection control
procedures, initiate appropriate antibiotic therapies for treating these
infections and improving patient management .

Burjeel Medical City  is constantly investing and establishing new
partnerships to identify cutting-edge medical technologies and innovations that
can help us deliver world-class healthcare to the people of the UAE.”

The
partnership will also explore new ways to boost improvement in rapid diagnosis while reducing
errors in the course of treatments. As part of the training, BD and Burjeel
Medical City  will also work on creating awareness of antimicrobial
resistance  (AMR) procedures. This will
lead to decreasing the risks of infections and maintaining adequate prevention
against prolonged illness, timely and accurate diagnostics, surveillance and
advanced medication management.